BeOne Medicines
ONC
#666
Rank
โ‚ฌ30.07 B
Marketcap
271,78ย โ‚ฌ
Share price
-0.55%
Change (1 day)
57.91%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): 0,39ย โ‚ฌ

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is 0,55ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -5,32ย โ‚ฌ.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)0,39ย โ‚ฌ-107.43%
2024-5,32ย โ‚ฌ
2022-16,61ย โ‚ฌ28.21%
2021-12,96ย โ‚ฌ-19.96%
2020-16,19ย โ‚ฌ20.81%
2019-13,40ย โ‚ฌ31.52%
2018-10,19ย โ‚ฌ417.57%
2017-1,97ย โ‚ฌ-37.16%
2016-3,13ย โ‚ฌ158.95%
2015-1,21ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-0,81ย โ‚ฌ-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-0,20ย โ‚ฌ-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA